Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:21 PM
Ignite Modification Date:
2026-03-26 @ 3:21 PM
NCT ID:
NCT01317927
Eligibility Criteria:
Inclusion Criteria:
* Informed consent
* Histological or cytological confirmed diagnosis of malignant disease
* Age ≥18 years old
* Adequate organ function
* ECOG 0-2
* Estimated life expectancy \>3months
* Negative pregnancy test for women of child bearing potential
Exclusion Criteria:
* Low dose anticoagulation therapy within 2 week prior to study treatment
* Anticancer therapy within 2 weeks prior to study treatment
* Investigational therapy within 4 weeks of study treatment
* Major surgery within 2 weeks of study treatment
* Coexisting active infection or other medical condition likely to interfere with trial procedures
* Significant cardiovascular disease (NYHA Class III or IV)
* Baseline prolongation of QT/QTc
* Clinically significant CNS disorder, altered mental status or psychiatric disorders precluding understanding of the informed consent process and/or completing trial procedures
* Symptomatic or untreated CNS metastases
* Pregnant or breast feeding women
* Patients not willing to use effective contraception
* Known infection with HIV, Hep B or Hep C
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01317927
Study Brief:
Protocol Section:
NCT01317927